Home » Topics » BioWorld Science

BioWorld Science
RSS

Targeting aggregated TDP-43 as new strategy for development of ALS and FTLD therapies

Jan. 11, 2022

Acadia and Stroke collaborate on novel RNA-based medicines for neurodevelopmental diseases

Jan. 11, 2022

HotSpot and Caris enter strategic partnership to advance HotSpot's portfolio

Jan. 11, 2022

Carisma and Moderna collaborate to generate and develop in vivo CAR-M therapeutics

Jan. 11, 2022

Tenaya expands heart disease pipeline with selection of TN-401 as development candidate

Jan. 11, 2022

Combination of rifampicin and resveratrol shows promise in models of neurodegenerative dementia

Jan. 11, 2022

Pfizer and Codex DNA collaborate to leverage EDS technology for mRNA-based vaccines

Jan. 11, 2022

Betta Pharmaceuticals discloses new HIF-2alpha inhibitors

Jan. 11, 2022

Surrozen advances research pipeline targeting Wnt pathway

Jan. 11, 2022

AC Immune synthesizes NLRP3 inflammasome inhibitors

Jan. 11, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...